The use of YM872, a competitive antagonist of AMPAR, to induce the apoptosis of glioblastoma cells, is in agreement with this assumption, confirming that perampanel suppresses tumor growth by inhibiting cell proliferation in AKT/ERK signaling (114). The gene discussed is AKT1; the disease is glioblastoma.